(2S,3R)-rel-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑-1-基)丁-2-醇 | CAS:188416-29-7

中文名称:	(2S,3R)-rel-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑-1-基)丁-2-醇
英文名称:	(2S,3R)-rel-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
CAS.No:	188416-29-7	CAS 相关:
MDL No:
分子式:	C₁₆H₁₄F₃N₅O
分子量:	349.31	密度:
熔点:		沸点:
储藏条件:
危险安全标识:

中文名称:

(2S,3R)-rel-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑-1-基)丁-2-醇

英文名称:

(2S,3R)-rel-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

CAS.No:

188416-29-7

CAS 相关:

MDL No:

分子式:

C₁₆H₁₄F₃N₅O

分子量:

349.31

密度:

熔点:

沸点:

储藏条件:

危险安全标识:

* 如果需要咨询更多不同包装的价格，请您联系客服为您查询报价。
* 订购成功后，将从离您最近的仓库发货，如果其中一个仓库中库存不足，我们将从另外一个仓库发货以减少交货时间。

中文名称：: (2S,3R)-rel-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑-1-基)丁-2-醇

中文别名：: 伏立康唑中间体II;（R*,S*）-α-(2,4-二氟苯基)-5-氟-β-甲基-α-(1H-1,2,4-三唑-1-甲基)-4-嘧啶乙醇;2,4-二羟基噻吩[2,3-D]嘧啶;伏立康唑中间体;伏立康唑;(R*,S*)-Α-(2,4-二氟苯基)-5-氟-Β-甲基-Α-(1H-1,2,4-三唑-1-基甲基)-4-嘧啶乙醇

英文名称：: (2S,3R)-rel-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

英文别名：: (2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;(2S,3R)-rel-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;Voriconazole Intermediate IV;2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)- 2-butanol;Voriconazole PI-6;(2R,3R)-Voriconazole;2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyriMidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (RaceMic Voriconazole);(2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butane-2-ol;SCHEMBL371715;188416-29-7;ent-Voriconazole;UNII-1Y58LNV43M;(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyriMidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (RaceMic Voriconazole);DTXSID60160114;4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaS,betaR)-; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, [S-(R*,S*)]-; Voriconazole Imp. D (EP); Voriconazole Related Compound B (USP);VORICONAZOLE IMPURITY D [EP IMPURITY];1Y58LNV43M;(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol- 1-yl)butan-2-ol;Voriconazole enantiomer;EPI-VORICONAZOLE;(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol;AKOS016844178;BCP11125;D84333;Q27253140;Voriconazole specified impurity D [EP];DS-11148;137234-63-0;C16H14F3N5O;EN300-7376311;AC-8178;4-PYRIMIDINEETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-, (.ALPHA.S,.BETA.R)-;BCEHBSKCWLPMDN-HWPZZCPQSA-N;4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaS,betaR)-